Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation. [electronic resource]
Producer: 20110923Description: 939-946 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Antineoplastic Agents, Alkylating -- administration & dosage
- Dexamethasone -- administration & dosage
- Double-Blind Method
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Isoquinolines -- administration & dosage
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Multiple Myeloma -- drug therapy
- Nausea -- chemically induced
- Palonosetron
- Quinuclidines -- administration & dosage
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.